Physician

Paul R Massey, MD

According to 2025 Medicare claims, Paul Massey, MD (NPI: 1174943690) practices dermatology in the Cheyenne, WY market, with the plurality of this provider's patient population coming from Laramie, WY. This provider's primary affiliated billing organization is CHEYENNE SKIN CLINIC LLP (NPI: 1740427509; TIN: 263996650) and primary practice location at 82009-3446.

Massey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 886 traditional Medicare patients, billed 5,221 HCPCS/CPT codes, and received $616,491 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 306 prescription claims across 191 beneficiaries totaling $62,740 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 27 records totaling $279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,765 to $616,491. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,293 and ending at $62,740. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$345K$690K2019 Medicare payment: $7,765 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $231,088 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $624,861 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $602,407 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $690,402 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $616,491 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193081$7,765
20204041,668$231,088
20218424,158$624,861
20228884,151$602,407
20239745,231$690,402
20248865,221$616,491

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$33K$65K2015 Drug cost: $2,293 (USD; Tot_Drug_Cst)2018 Drug cost: $12,334 (USD; Tot_Drug_Cst)2019 Drug cost: $65,226 (USD; Tot_Drug_Cst)2020 Drug cost: $24,808 (USD; Tot_Drug_Cst)2021 Drug cost: $38,803 (USD; Tot_Drug_Cst)2022 Drug cost: $10,574 (USD; Tot_Drug_Cst)2023 Drug cost: $9,739 (USD; Tot_Drug_Cst)2024 Drug cost: $62,740 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151443$2,293
2016N/RN/RN/R
2017N/RN/RN/R
20183142$12,334
2019103173$65,226
2020120192$24,808
2021184310$38,803
2022188331$10,574
2023191297$9,739
2024191306$62,740

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks249290$451
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more399551$60
11102Biopsy of related skin growth, first growth231266$47
17000Destruction of precancer skin growth, 1 growth260342$31
17003Destruction of precancer skin growth, 2-14 growths168545$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil361,032$2,589
Clobetasol PropionateClobetasol Propionate22633$862
ImiquimodImiquimod13368$606
KetoconazoleKetoconazole371,133$559
CephalexinCephalexin74580$437

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$279ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Paul R. Massey, MD?

Tedicare shows public-source Medicare data for Paul R. Massey, MD (NPI 1174943690), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul R. Massey, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul R. Massey, MD?

Paul R. Massey, MD is linked to CHEYENNE SKIN CLINIC LLP (billing NPI 1740427509) in the available physician profile data.

Does Paul R. Massey, MD have Open Payments data?

Paul R. Massey, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.